Want to see GALT full AI Analyst Report?
Galectin Therapeutics (GALT) Ownership Overview
26.04% Insiders
3.90% Mutual Funds
0.02% Other Institutional Investors
5.50% ETFs
64.55% Public Companies and
Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 9.42% of the company’s stock is owned by Institutional Investors, 26.04% is owned by Insiders, and 64.55% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 09, 2026 | xxxxxxxxxxxxx | $810 | |
Jan 13, 2026 | xxxxxxxxxxxxx | $218568 | |
Dec 23, 2025 | xxxxxxxxxxxxx | $19470 | |
Dec 23, 2025 | xxxxxxxxxxxxx | $2611 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,360,386 | Insider | 15.73% | 49,315,437 | |
| 5,614,457 | Insider | 8.53% | 26,724,815 | |
| 1,946,148 | Institution | 2.96% | 9,263,664 | |
| 1,915,073 | Institution | 2.91% | 9,115,747 | |
| 1,550,997 | Institution | 2.36% | 7,382,746 | |
| 778,260 | Insider | 1.18% | 3,704,518 | |
| 536,264 | Institution | 0.81% | 2,552,617 | |
| 137,269 | Insider | 0.21% | 653,400 | |
| 70,107 | Insider | 0.11% | 333,709 | |
| 66,769 | Insider | 0.10% | 317,820 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,915,073 | Institution | 2.91% | 9,115,747 | |
| 536,264 | Institution | 0.81% | 2,552,617 | |
| 29,970 | Institution | 0.05% | 142,657 | |
| 26,902 | Institution | 0.04% | 128,054 | |
| 24,567 | Institution | 0.04% | 116,939 | |
| 22,865 | Institution | 0.03% | 108,837 | |
| 7,750 | Institution | 0.01% | 36,890 | |
| 5,212 | Institution | <0.01% | 24,809 | |
| 1,086 | Institution | <0.01% | 5,169 | |
| 289 | Institution | <0.01% | 1,376 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,521,443 | Institution | 2.31% | 7,059,496 | |
| 954,394 | Institution | 1.45% | 4,542,915 | |
| 595,153 | Institution | 0.90% | 2,761,510 | |
| 309,082 | Institution | 0.47% | 1,471,230 | |
| 275,017 | Institution | 0.42% | 1,276,079 | |
| 161,649 | Institution | 0.25% | 769,449 | |
| 111,784 | Institution | 0.17% | 532,092 | |
| 46,968 | Institution | 0.07% | 250,809 | |
| 35,584 | Institution | 0.05% | 165,110 | |
| 22,402 | Institution | 0.03% | 119,627 |
FAQ
Who Owns Galectin Therapeutics (GALT) (GALT)?
According to the latest TipRanks data, approximately 0.02% of the company's stock is held by institutional investors, 26.04% is held by insiders, and 64.55% is held by retail investors.
What percentage of Galectin Therapeutics (GALT) (GALT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.02% of Galectin Therapeutics (GALT) (GALT) stock is held by institutional investors.
What percentage of Galectin Therapeutics (GALT) (GALT) stock is held by retail investors?
According to the latest TipRanks data, approximately 64.55% of Galectin Therapeutics (GALT) (GALT) stock is held by retail investors.
Who owns the most shares of Galectin Therapeutics (GALT) (GALT)?
Richard E Uihlein owns the most shares of Galectin Therapeutics (GALT) (GALT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.